Recent Quotes

My Watchlist

Indicators

Boundless Bio Inc (NQ: BOLD )

2.980 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	2.980
Bid (Size)	1.200 (2)
Ask (Size)	4.760 (2)
Prev. Close	2.980
Today's Range	2.980 - 2.980
52wk Range	2.820 - 14.72
Shares Outstanding	45,783,265
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Boundless Bio Announces Departure of Chief Financial Officer

October 14, 2024

From Boundless Bio, Inc.

Via GlobeNewswire

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

September 11, 2024

From Boundless Bio, Inc.

Via GlobeNewswire

Performance

YTD	-79.09%	-79.09%
1 Month	-6.29%	-6.29%
3 Month	-0.67%	-0.67%
6 Month	-69.62%	-69.62%
1 Year	-79.09%	-79.09%

More News

BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024

August 12, 2024

Via InvestorPlace

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

August 12, 2024

From Boundless Bio, Inc.

Via GlobeNewswire

BOLD Stock Earnings: Boundless Bio Reported Results for Q1 2024

May 13, 2024

Via InvestorPlace

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

June 05, 2024

From Boundless Bio

Via Business Wire

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

May 13, 2024

From Boundless Bio

Via Business Wire

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

May 06, 2024

From Boundless Bio

Via Business Wire

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

April 11, 2024

From Boundless Bio

Via Business Wire

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

April 08, 2024

From Boundless Bio

Via Business Wire

Bayer-Backed Boundless Bio Falls After IPO

March 31, 2024

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.